The Oncologist - neue Veröffentlichungen des Onkologischen Zentrums

ONClogo
 Im April hat Prof. (SHB) Dr. med. Dirk Hempel zwei neue Studien in der wissenschaftlichen Fachzeitschrift "The Oncologist" veröffentlicht.

Hier finden Sie die Links zu den Studien zum Download:

Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene AmplificationQR Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification

 Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionQR Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction